Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.55 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.52 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10589772 | 0.86 | GABRA1 (0.48) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL19704411 | 0.84 | CYP1A2 (0.46) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL28258800 | 0.84 | CYP1A2 (0.46) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL2269883 | 0.83 | ALDH1A1 (0.50) | CYP1A2CYP3A4CYP2B6GAALMNA | |
| SCHEMBL4078873 | 0.79 | TSHR (0.42) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL5200323 | 0.77 | CA1 (0.56) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL6284758 | 0.77 | TYR (0.41) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL19704412 | 0.77 | CYP1A2 (0.40) | CA1CA2CYP1A2CYP3A4CYP2B6 | |
| SCHEMBL3429786 | 0.77 | KDM4E (0.57) | CYP1A2CYP3A4CYP2B6GABRA1GABRB2 | |
| SCHEMBL19704222 | 0.77 | CYP1A2 (0.39) | CA1CA2CYP1A2CYP3A4CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751232-A | Flavonoid derivative, preparation method thereof, pharmaceutical composition and application | 深圳市人民医院 | 2025-04-04 | — | — | CN | claimed |
| CN-110862335-B | Preparation method of VEGFR2 selective inhibitor SU1498 | 安莱博医药(苏州)有限公司 | 2022-03-15 | — | — | CN | claimed |
| CN-110862335-A | Preparation method of VEGFR2 selective inhibitor SU1498 | 安莱博医药(苏州)有限公司 | 2020-03-06 | — | — | CN | claimed |
| CN-1589136-A | Pharmaceutical and cosmetic compositions containing aromatic aldehydes bearing oxygen-containing groups | CUTANIX CORP (US) | 2005-03-02 | — | — | CN | claimed |
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | CUTANIX CORPORATION | 2003-08-21 | — | — | US | claimed |
| JP-61218558-A | — | — | None | — | — | JP | disclosed |
| JP-61012674-A | — | — | None | — | — | JP | disclosed |
| JP-62029579-A | — | — | None | — | — | JP | disclosed |
| JP-62039522-A | — | — | None | — | — | JP | disclosed |
| CN-119751232-A | Flavonoid derivative, preparation method thereof, pharmaceutical composition and application | 深圳市人民医院 | 2025-04-04 | — | — | CN | disclosed |
| CN-114149311-B | Method for preparing 4-hydroxybenzophenone compound by taking p-methylene quinone as substrate | 上海应用技术大学 | 2023-11-03 | — | — | CN | disclosed |
| US-11584742-B2 | Substituted aminothiazoles as inhibitors of nucleases | MASARYKOVA UNIVERZITA (CZ) | 2023-02-21 | — | — | US | disclosed |
| JP-S6239522-A | ANTIENZYME | KANEGAFUCHI CHEM IND CO LTD | 1987-02-20 | — | — | JP | disclosed |
| JP-S6229579-A | 4-THIAZOLINONE DERIVATIVE | KANEGAFUCHI CHEM IND CO LTD | 1987-02-07 | — | — | JP | disclosed |
| JP-S61218558-A | 3,5-DIISOPROPYL-4-HYDROXYSTYRENE DERIVATIVE | KANEGAFUCHI CHEM IND CO LTD | 1986-09-29 | — | — | JP | disclosed |
| JP-S6112674-A | NOVEL IMIDAZOLIDINEDIONE AND ANTIALLERGIC | KANEGAFUCHI CHEM IND CO LTD | 1986-01-21 | — | — | JP | disclosed |
| EP-0090506-A2 | Lubricant compositions containing a dithiophosphoric acid ester-aldehyde reaction product | MOBIL OIL CORPORATION (US) | 1983-10-05 | — | — | EP | disclosed |
| US-4405470-A | LUBRICANTS; OXIDATION AND WEAR RESISTANCE | MOBIL OIL CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4048171-A | 1,4-Dihydropyridines | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-13 | — | — | US | disclosed |
| US-3966948-A | Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584742-B2 | Substituted aminothiazoles as inhibitors of nucleases | RNASEH1, DNASE1, FEN1 | CA1 4610/4885CA2 4586/4885CYP1A2 4393/4885 |
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | TYR, HRH1, HRH2 | CA1 4354/4885CA2 3996/4885CYP1A2 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.